Table of Contents
International Scholarly Research Notices
Volume 2017 (2017), Article ID 6053267, 4 pages
https://doi.org/10.1155/2017/6053267
Research Article

Frequency of Neurological Disorders in Bullous Pemphigoid Patients: A Cross-Sectional Study

1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
2Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3Dermatology Department, Shiraz University of Medical Sciences, Shiraz, Iran
4Department of Comprehensive Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

Correspondence should be addressed to Nasrin Saki

Received 5 April 2017; Accepted 4 May 2017; Published 24 May 2017

Academic Editor: Mauro Alaibac

Copyright © 2017 Sheida Khosravani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kasperkiewicz and D. Zillikens, “The pathophysiology of bullous pemphigoid,” Clinical Reviews in Allergy and Immunology, vol. 33, no. 1-2, pp. 67–77, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Pietkiewicz, J. Gornowicz-Porowska, M. Bowszyc-Dmochowska, P. Bartkiewicz, and M. Dmochowski, “Bullous pemphigoid and neurodegenerative diseases: a study in a setting of a Central European university dermatology department,” Aging Clinical and Experimental Research, vol. 28, no. 4, pp. 659–663, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. C. L. Leung, M. Zheng, S. M. Prater, and R. K. H. Liem, “The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles,” Journal of Cell Biology, vol. 154, no. 4, pp. 691–697, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Poliakova, A. Adebola, C. L. Leung et al., “BPAG1a and b associate with EB1 and EB3 and Modulate vesicular transport, golgi apparatus structure, and cell migration in C2.7 myoblasts,” PLoS One, vol. 9, article e107535, Sep 22, no. 9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Schmidt, R. della Torre, and L. Borradori, “Clinical features and practical diagnosis of bullous pemphigoid,” Dermatologic Clinics, vol. 29, no. 3, pp. 427–438, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Joly, S. Baricault, A. Sparsa et al., “Incidence and mortality of bullous pemphigoid in France,” Journal of Investigative Dermatology, vol. 132, no. 8, pp. 1998–2004, 2012, Aug. View at Publisher · View at Google Scholar · View at Scopus
  7. S. M. Langan, L. Smeeth, R. Hubbard, K. M. Fleming, C. J. P. Smith, and J. West, “Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study,” British Medical Journal, vol. 337, no. 7662, pp. 160–163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Sobhan, M. Farshchian, and M. Tamimi, “Spectrum of autoimmune vesiculobullous diseases in Iran: A 13-year retrospective study,” Clinical, Cosmetic and Investigational Dermatology, vol. 9, pp. 15–20, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Esmaili, Z. Hallaji, T. Soori, and C. H. Davatchi, “Bullous pemphigoid in iranian patients: a descriptive study on 122 cases,” Acta Medica Iranica, vol. 50, no. 5, pp. 335–338, 2012. View at Google Scholar · View at Scopus
  10. K. Taghipour, C.-C. Chi, B. Bhogal, R. W. Groves, V. Venning, and F. Wojnarowska, “Immunopathological characteristics of patients with bullous pemphigoid and neurological disease,” Journal of the European Academy of Dermatology and Venereology, vol. 28, no. 5, pp. 569–573, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Stinco, R. Codutti, M. Scarbolo, F. Valent, and P. Patrone, “A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases,” Acta Dermato-Venereologica, vol. 85, no. 2, pp. 136–139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Taghipour, C.-C. Chi, A. Vincent, R. W. Groves, V. Venning, and F. Wojnarowska, “The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study,” Archives of Dermatology, vol. 146, no. 11, pp. 1251–1254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. Langan, R. W. Groves, and J. West, “The relationship between neurological disease and bullous pemphigoid: A population-based case-control study,” Journal of Investigative Dermatology, vol. 131, no. 3, pp. 631–636, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Cordel, O. Chosidow, M.-F. Hellot et al., “Neurological disorders in patients with bullous pemphigoid,” Dermatology, vol. 215, no. 3, pp. 187–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. V. B. Teixeira, R. Cabral, M. M. Brites, R. Vieira, and A. Figueiredo, “Bullous pemphigoid and comorbidities: A case-control study in Portuguese patients,” Anais Brasileiros de Dermatologia, vol. 89, no. 2, pp. 274–279, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. M. Tarazona, N. Unterstell, A. N. C. D. M. Mota, A. L. Bressan, and A. C. Gripp, “Bullous pemphigoid and neurological disease: statistics from a dermatology service,” Anais Brasileiros de Dermatologia, vol. 90, no. 2, pp. 280–282, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Bernard, C. Bedane, and J.-M. Bonnetblanc, “Anti‐BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients,” British Journal of Dermatology, vol. 136, no. 5, pp. 694–698, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Chevalier, C. Barbe, Z. Reguiai, J. Plée, F. Grange, and P. Bernard, “Impact of neurological diseases on the prognosis of bullous pemphigoid: a retrospective study of 178 patients,” Annales de Dermatologie et de Venereologie, vol. 143, no. 3, pp. 179–186, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Chen, L. Li, J. Chen et al., “Sera of elderly bullous pemphigoid patients with associated neurological diseases recognize bullous pemphigoid antigens in the human brain,” Gerontology, vol. 57, no. 3, pp. 211–216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Laffitte, P. R. Burkhard, L. Fontao et al., “Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?” British Journal of Dermatology, vol. 152, no. 3, pp. 537–540, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Fichel, C. Barbe, P. Joly et al., “Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study,” JAMA Dermatology, vol. 150, no. 1, pp. 25–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Cortés, G. Marazza, L. Naldi, C. Combescure, and L. Borradori, “Autoimmune bullous disease swiss study group. mortality of bullous pemphigoid in switzerland: a prospective study,” British Journal of Dermatology, vol. 165, no. 2, pp. 368–374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Nakane, Y. Izumi, M. Oda, R. Kaji, and H. Matsuo, “A potential link between amyotrophic lateral sclerosis and bullous pemphigoid: six new cases and a systematic review of the literature,” Internal Medicine, vol. 55, no. 15, pp. 1985–1990, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-I. Oh, J. H. Hong, B. W. Choi et al., “A novel F45S SOD1 mutation in amyotrophic lateral sclerosis coexisting with bullous pemphigoid,” Journal of Clinical Neurology, vol. 11, no. 4, pp. 390–394, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. D. A. García-Estévez, G. Peón-Currás, and F. Bal-Nieves, “Bullous pemphigoid and amyotrophic lateral sclerosis,” Revista de Neurologia, vol. 47, no. 10, pp. 525-526, 2008. View at Google Scholar · View at Scopus
  26. O. Chosidow, V. Doppler, G. Bensimon et al., “Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease?” Archives of Dermatology, vol. 136, no. 4, pp. 521–524, 2000. View at Google Scholar · View at Scopus
  27. S. Simjee, A. Konqui, and A. Razzaque Ahmed, “Multiple sclerosis and bullous pemphigoid,” Dermatology, vol. 170, no. 2, pp. 86–89, 1985. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Kirtschig, V. M. Walkden, V. A. Venning, and F. Wojnarowska, “Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature,” Clinical and Experimental Dermatology, vol. 20, no. 6, pp. 449–453, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Peramiquel, M. A. Barnadas, C. L. Pimentel et al., “Bullous pemphigoid and multiple sclerosis: a report of two cases with ELISA test,” European Journal of Dermatology, vol. 17, no. 1, pp. 62–66, 2007, Feb 27, Epub. View at Google Scholar
  30. G. Stinco, P. Mattighello, M. Zanchi, and P. Patrone, “Multiple sclerosis and bullous pemphigoid: a casual association or a pathogenetic correlation?” European Journal of Dermatology, vol. 12, no. 2, pp. 186–188, 2002. View at Google Scholar · View at Scopus
  31. S. Bastuji-Garin, P. Joly, P. Lemordant et al., “French study group for bullous diseases. risk factors for bullous pemphigoid in the elderly: a prospective casecontrol study,” Journal of Investigative Dermatology, vol. 131, no. 3, pp. 637–643, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. K. Försti, J. Jokelainen, H. Ansakorpi et al., “Psychiatric and neurological disorders are associated with bullous pemphigoid—a nationwide Finnish Care Register study,” Scientific Reports, vol. 6, article 37125, 2016. View at Publisher · View at Google Scholar
  33. H. Jedlickova, M. Hlubinka, T. Pavlik, V. Semradova, E. Budinska, and Z. Vlasin, “Bullous pemphigoid and internal diseases—a case-control study,” European Journal of Dermatology, vol. 20, no. 1, pp. 96–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. Y.-W. Yang, Y.-H. Chen, S. Xirasagar, and H.-C. Lin, “Increased risk of stroke in patients with bullous pemphigoid: A population-based follow-up study,” Stroke, vol. 42, no. 2, pp. 319–323, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. K. E. Brick, C. H. Weaver, R. Savica et al., “A population-based study of the association between bullous pemphigoid and neurologic disorders,” Journal of the American Academy of Dermatology, vol. 71, no. 6, pp. 1191–1197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Kwan, N. Lai, g. C. Ch et al., “The association between bollous pemphigoid and neurological disorders in a selected malaysian population,” Medical Journal of Malaysia, vol. 70, no. 2, pp. 81–85, Apr 2015. View at Google Scholar
  37. M. Daneshpazhooh, J. Khorassani, K. Balighi et al., “Neurological diseases and bullous pemphigoid: a case-control study in iranian patients,” Indian Journal of Dermatology, Venereology, and Leprology, vol. 83, no. 2, pp. 195–199, 2017. View at Publisher · View at Google Scholar